Searched for
ARJUN BHARTIA
Conversations around gut health have increased, as have misconceptions. What is needed is a comprehensive approachUnderstanding gut health involves more than following diet trends. Poor gut health, linked to stress, poor diet, and lifestyle choices, req...- Buy Awfis Space Solutions, target price Rs 1,049: ICICI SecuritiesICICI Securities maintains a buy rating for Awfis Space Solutions, raising the target price to Rs 1049 from Rs 730.2. Awfis reported strong...
- Vedanta Director Priya Agarwal to join WEF's Young Global Leaders Class of 2024Priya Agarwal Hebbar, from Hindustan Zinc Limited and Vedanta Limited, is part of the WEF's Young Global Leaders 2024 cohort. She collabora...
- Shashwat Goenka to join World Economic Forum's Young Global Leaders Class of 2024Other class members from India Inc for this year include FSN E-Commerce Ventures (NYKAA) CEO Adwaita Nayar, Jubilant Group director Arjun B...
- Buy Jubilant Ingrevia, target price Rs 475: Axis SecuritiesJubilant Ingrevia, incorporated in the year 2019, is a Small Cap company (having a market cap of Rs 6768.65 Crore) operating in Chemicals s...
- Jubilant Pharmova announces leadership changes; Priyavrat Bhartia takes over as MDJubilant Pharmova Ltd on Tuesday announced leadership changes and board composition with Priyavrat Bhartia being appointed as Managing Dire...
- Buy Jubilant Ingrevia, target price Rs 593: HDFC SecuritiesStock price has been in an uptrend as per the positive chart pattern like higher tops and bottoms.
- Buy Jubilant Pharmova, target price Rs 475: Anand RathiJubilant Pharmova, incorporated in the year 1978, is a Mid Cap company (having a market cap of Rs 6501.86 Crore) operating in Pharmaceutica...
- Buy Jubilant Ingrevia, target price Rs 860: Prabhudas LilladherFor the quarter ended June 30, 2022, the company has reported a consolidated total income of Rs 1175.90 crore, down 9.89 per cent from last...
- Buy Jubilant Life Sciences, price target Rs 580: Kunal BothraThe analyst suggested a stoploss at Rs 537 .
- Buy Jubilant Life Sciences, price target Rs 575: Kunal BothraThe analyst suggested a stoploss at Rs 533.
- Realtor KP Singh’s granddaughter buys property on Prithviraj Road for Rs 477 croreThe bungalow located on a 7,143-sqm plot with a built-up area of 780-sqm was sold by the family of the late war hero Air Chief Marshal Prat...
- Neutral Jubilant Life Sciences, target Rs 905: Motilal Oswal SecuritiesMotilal Oswal Securities is neutral Jubilant Life Sciences at a price target of Rs 905. The time period given to achieve the target is a qu...
- Jubilant Life appoints Priyavrat Bhartia, Arjun Shanker as directorsPriyavrat Bhartia is the son of Chairman Shyam S Bhartia while Arjun Shanker Bhartia is the son of co-Chairman and Managing Director Hari S...
- Next-Gen India Inc leaders ready for Davos jamboreeThose registered for the World Economic Forum (WEF) Annual Meeting, beginning January 19, include Karan Adani, son of billionaire industria...
- The Eatopians: The food entrepreneurs who are betting big on IndiaThanks to these 160 million mouths, India is in the midst of a gastronomic revolution. Indians are willing to experiment.
Load More
